Business Description
Poly Medicure Ltd
ISIN : INE205C01021
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.18 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 0.34 | |||||
Interest Coverage | 28.57 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 27.96 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.1 | |||||
3-Year EBITDA Growth Rate | 14.8 | |||||
3-Year EPS without NRI Growth Rate | 20.6 | |||||
3-Year Book Growth Rate | 38 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 83.8 | |||||
9-Day RSI | 74.14 | |||||
14-Day RSI | 66.89 | |||||
6-1 Month Momentum % | 13.05 | |||||
12-1 Month Momentum % | 62.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.53 | |||||
Quick Ratio | 1.87 | |||||
Cash Ratio | 0.92 | |||||
Days Inventory | 134.35 | |||||
Days Sales Outstanding | 66.01 | |||||
Days Payable | 60.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.18 | |||||
Dividend Payout Ratio | 0.12 | |||||
3-Year Dividend Growth Rate | -14.5 | |||||
Forward Dividend Yield % | 0.18 | |||||
5-Year Yield-on-Cost % | 0.18 | |||||
3-Year Average Share Buyback Ratio | -2.8 | |||||
Shareholder Yield % | 0.09 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.88 | |||||
Operating Margin % | 22.52 | |||||
Net Margin % | 19.16 | |||||
FCF Margin % | -3.73 | |||||
ROE % | 20.09 | |||||
ROA % | 15.8 | |||||
ROIC % | 19.1 | |||||
ROC (Joel Greenblatt) % | 34.94 | |||||
ROCE % | 26.32 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 63.07 | |||||
PE Ratio without NRI | 63.07 | |||||
Shiller PE Ratio | 136.17 | |||||
Price-to-Owner-Earnings | 135.84 | |||||
PEG Ratio | 3.97 | |||||
PS Ratio | 12.08 | |||||
PB Ratio | 11.71 | |||||
Price-to-Tangible-Book | 12.28 | |||||
Price-to-Operating-Cash-Flow | 82.19 | |||||
EV-to-EBIT | 46.23 | |||||
EV-to-EBITDA | 39 | |||||
EV-to-Revenue | 12.01 | |||||
EV-to-FCF | -320.27 | |||||
Price-to-Projected-FCF | 16.46 | |||||
Price-to-DCF (Earnings Based) | 2.84 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.62 | |||||
Price-to-Graham-Number | 6.07 | |||||
Price-to-Net-Current-Asset-Value | 34.79 | |||||
Earnings Yield (Greenblatt) % | 2.16 | |||||
FCF Yield % | -0.31 | |||||
Forward Rate of Return (Yacktman) % | 15.88 |